News & Resources

DiObex is a biotechnology company engaged in the development of novel products for diabetes.

Our pipeline includes two programs which address a significant unmet medical need in the prevention of insulin induced hypoglycemia, a major limitation in the aggressive management of hyperglycemia in diabetes.